Analytical Data
-
基因名
CTHRC1
- Application
-
别名
CTHRC1;Collagen triple helix repeat-containing Protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96CG8
-
表达区间
31-243aa
-
氨基酸序列
SEIPKGKQKA QLRQREVVDL YNGMCLQGPA GVPGRDGSPG ANGIPGTPGI PGRDGFKGEK GECLRESFEE SWTPNYKQCS WSSLNYGIDL GKIAECTFTK MRSNSALRVL FSGSLRLKCR NACCQRWYFT FNGAECSGPL PIEAIIYLDQ GSPEMNSTIN IHRTSSVEGL CEGIGAGLVD VAIWVGTCSD YPKGDASTGW NSVSRIIIEE LPK
-
分子量
24 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTHRC1 (Collagen triple helix repeat containing 1) is a protein that has garnered significant attention in recent years due to its pivotal role in various biological processes, including tissue remodeling, wound healing, and tumor progression. Initially discovered as a gene upregulated during wound healing, CTHRC1 is involved in the regulation of collagen deposition and has been implicated in the modulation of cell migration and differentiation. Research indicates that CTHRC1 enhances the invasive properties of cancer cells, making it a potential biomarker for aggressive tumors and a target for novel therapeutic strategies. As a result, the recombinant expression and characterization of CTHRC1 protein have become critical for understanding its functional mechanisms and potential applications in regenerative medicine and cancer biology. By producing CTHRC1 in a recombinant system, researchers aim to investigate its interactions with other proteins, its role in the extracellular matrix, and its therapeutic implications, thereby enhancing our knowledge of its contribution to both physiological and pathological processes. Ultimately, the study of recombinant CTHRC1 protein holds promise for advancing treatments for fibrotic diseases and cancer interventions.
